Focus A-Eye LLC will host its inaugural Focus A-Eye Summit on May 2 in Denver, aiming to accelerate the adoption of artificial intelligence across ophthalmology and reshape the future of eye care. The event brings together clinicians, researchers, pharmaceutical leaders, device manufacturers, and AI developers for a collaborative exchange on innovation and real-world implementation.
Organizers describe the Summit as a first-of-its-kind interdisciplinary forum designed to foster collaboration across the full spectrum of eye care. Participants will explore how AI tools can improve diagnostic accuracy, streamline workflows, and enhance patient outcomes while addressing barriers to adoption in clinical settings.
The Summit will focus on integrating AI into everyday ophthalmic practice, supporting research advancements, and improving operational efficiency. Discussions will also examine scalability, regulatory considerations, and the ethical deployment of AI technologies in healthcare environments.
READ: AI was built in layers—now doctors must be trained on it fast (
The program features leading experts, including Dr. Sharon Bakalash, Kristine Morrill, Dr. Malvina Eydelman, Professor Anat Loewenstein, Dr. Omer Trivizki, Dr. I. Paul Singh, Dr. Devinder Chauhan, and keynote speaker Euan Thomson. Their combined expertise spans clinical care, regulatory policy, research innovation, and technology development.“Artificial intelligence has reached an inflection point in ophthalmology, but meaningful adoption requires collaboration across disciplines,” said Dr. Sharon Bakalash, founder of Focus A-Eye. She emphasized that rapid advances in imaging, diagnostics, and predictive analytics have created new opportunities, yet fragmentation across stakeholders has slowed implementation. By convening experts in one forum, the summit aims to convert innovation into practical, patient-centered solutions that can be deployed widely and responsibly.
Focus A-Eye Co-Founder Kristine Morrill added, “Our goal is to create a platform where clinical insight, technological innovation, and commercial strategy converge, enabling AI solutions that are both scalable and impactful.” She noted that many promising AI tools struggle to move beyond pilot stages due to gaps between developers and end users. The summit seeks to align these groups, ensuring that emerging technologies address real clinical needs while remaining viable in competitive healthcare markets.
As AI continues to transform medicine, the Focus A-Eye Summit positions itself as a key step toward integrating advanced technologies into ophthalmology. By promoting collaboration and practical solutions, organizers hope to accelerate progress and deliver measurable improvements in patient care.
Focus A-Eye operates as a specialized medical education and innovation platform dedicated to advancing AI applications in ophthalmology. The organization aims to bridge gaps between clinical practice, research, and emerging technologies, positioning itself as a catalyst for meaningful change in the diagnosis, management, and treatment of eye diseases.